Background Depression and anxiety disorders are common mental disorders worldwide. The MANAS trial aimed to test the eff ectiveness of an intervention led by lay health counsellors in primary care settings to improve outcomes of people with these disorders.
Introduction
Depressive and anxiety disorders (the so-called common mental disorders) are the leading neuropsychiatric cause of the global burden of disease and are associated with an increased risk of suicide, increased health-care costs, and reduced economic productivity. [1] [2] [3] [4] The prevalence of these disorders varies substantially between primary care settings with a mean of 20% from a study of 14 countries, 5 but recognition of these disorders is poor, with less than a third of clinically signifi cant cases identifi ed. 6 Although evidence of the effi cacy of antidepressant drugs and brief psychological treatments for common mental disorders has long been available, [7] [8] [9] [10] [11] there are several obstacles to providing eff ective interventions to real-world primary care settings in developing countries. [12] [13] [14] These obstacles include the low recognition rate of these disorders by primary care doctors, the inadequate use of antidepressant drugs or psychosocial treatments, and low adherence to treatments. In a systematic review 15 of the constituents of collaborative care interventions for primary care management of these disorders, the use of routine screening, the professional skills of staff , and specialist supervision predicted a favourable outcome. Task shifting is an increasingly advocated method that can alleviate shortages in specialist health human resources. 16, 17 We undertook a cluster randomised controlled trial (MANAS; MANashanti Sudhar Shodh, which means "project to promote mental health" in Konkani) to systematically develop an intervention for common mental disorders that aimed to address these barriers in routine primary health care in Goa, India. 18 More than half of all primary care consultations in India take place in the private sector. 19 We aimed to assess the eff ectiveness of collaborative stepped-care interventions led by lay health counsellors on patients' recovery from common mental disorders in primary health-care settings (both public primary health centre [PHC] and private general practitioner [GP] settings) in Goa, India.
Methods

Study design and patients
This cluster randomised controlled trial was done in two consecutive phases from April, 2007, to September, 2009, in 12 PHCs (phase 1) and in 12 GP facilities (phase 2). A randomised design with the health facility as the unit of randomisation was chosen to prevent contamination between individuals.
Adults older than 17 years were screened if: they spoke Konkani, Marathi, Hindi, or English; did not need urgent medical attention; did not have diffi culty with hearing, speaking, or cognition, which could make interviewing diffi cult; had not already been screened in the previous 2 weeks; and were not already receiving the intervention. Those who screened positive for common mental disorders with the 12-item general health questionnaire (GHQ; with a previously validated cutoff score of >5) 20 and who expected to be resident in Goa for the subsequent 12 months were invited to participate in the trial. If the patient gave written consent (or verbal consent for illiterate individuals), a structured clinical diagnostic interview for use by trained lay interviewers (the revised clinical interview schedule [CIS-R]) 21 was administered to provide a baseline assessment of severity and diagnostic categorisation.
Details about trial protocol approval and consent have been published previously. 22 The trial was approved by the Institutional Review Boards of the London School of Hygiene and Tropical Medicine and Sangath, the Indian Council of Medical Research, and an independent Trial Steering Committee. In Phase 1, facility consent was obtained from the Government of Goa's Directorate of Health Services. In Phase 2, facility consent was obtained from each GP. Individual participant consent was obtained in two stages: after the screening, those who screened positive were invited to participate in the CIS-R interview and be enrolled in the trial. Written consent was again obtained by the fi eld researcher at the time of the outcome assessment.
Randomisation and masking
The sampling frames included all facilities with the space and privacy for lay health counsellors, had regular outpatient clinics, and were not involved in preliminary phases of the project. For phase 1, 17 facilities in Goa met these inclusion criteria, of which 12 were randomly selected for inclusion in the trial. PHC facilities were fi rst stratifi ed by the presence or absence of a visiting psychiatrist and then randomised within four strata defi ned by size. For phase 2, we sent out 400 letters to GPs from a list of all registered medical GPs in the state; eight responded. The research team then visited a purposively selected subsample of GPs who had not responded (n=60). Thus, altogether, 68 GPs were visited and assessed for eligibility; 25 did not meet our a-priori eligibility criteria and 21 declined to participate. 12 of the 22 eligible GP facilities were randomly selected for phase 2 of the trial. The 12 GP facilities were randomised within two strata defi ned by size. For both phases, facilities were randomly allocated within each stratum to either the intervention or control arm using a 1:1 allocation ratio using a computer-generated randomisation sequence.
Masking of the research assessor was maximised by: undertaking assessments at home; randomly allocating unique identifi cation numbers to patients so that there was no association between their number and the identity of the facility; outcome assessment being done by an independent institution whose team did not know the randomisation allocation; and undertaking the primary outcome assessment before all other assessments.
Interventions
All interventions were implemented at the individual level within clusters. The formative and piloting work leading to the design of the collaborative stepped-care intervention has been described previously. 18 In brief, the intervention is based on the stepped-care approach, which emphasises the effi cient use of scarce resources. The collaborative approach involves three key team members: the lay health counsellor, the primary care physician, and a visiting psychiatrist (the clinical specialist). The locally recruited lay health counsellors did not have health backgrounds and underwent a structured 2-month training course. Lay health counsellors acted as a case-manager for all patients who screened positive for common mental disorders, and took overall responsibility for delivering all the non-drug treatments in close collaboration with the primary care physician and the clinical specialist, with the ultimate goal of a planned discharge on recovery. Table 1 provides the steps of the collaborative stepped-care intervention.
Psychoeducation provided by the lay health counsellor to all patients who screened positive for common mental disorders focused on educating the person about their symptoms, the association of common mental disorders with interpersonal diffi culties, and the need to share emotional symptoms with the doctor and to share personal diffi culties with family members caring for them or other key people in their social network (derived from the initial phase of interpersonal psychotherapy). Psychoeducation taught patients strategies to alleviate symptoms, such as breathing exercises for anxiety symptoms and scheduling activities for symptoms of depression. Encouraging adherence to treatments for these disorders and providing information about social and welfare organisations when needed were other key components of psychoeducation. Antidepressant drugs were recommended only for moderate or severe common mental disorders (ie, with a GHQ score >7) and for those who did not respond to psychoeducation alone on the basis of routine clinical assessments by the lay health counsellor. The antidepressant used, fl uoxetine, was provided by the project to integrate with the existing model of free drugs prescribed by the PHC doctor. In the GP clinics, doctors could prescribe antidepressant drugs of their choice, from recommendations off ered in a manual that provided information about commonly available drugs and their side-eff ects and costs, 23 which were purchased by patients as usual. Once initiated, antidepressant drugs were recommended for a minimum of 90 days at an adequate dose (at least 20 mg per day of fl uoxetine or the equivalent, which could be titrated up to 40 mg if clinical response was inadequate). Physicians were given training for half a day and a manual. The other key roles of the physicians were to encourage patients to meet the lay health counsellor, to avoid the use of unnecessary drugs, and to provide usual care for any coexisting physical health problems.
Interpersonal psychotherapy, delivered by the lay health counsellor, was the structured psychological intervention chosen because of its documented feasibility and eff ectiveness in Uganda, another low-income country, 24 and because of its focus on interpersonal problems such as grief, disputes, and role transitions, which were common in the adverse life experiences of participants in previous research in Goa. 25 A minimum of six sessions, with an optimum of eight and a maximum of 12, were off ered. Interpersonal psychotherapy was reserved only for patients who had moderate or severe common mental disorders, and was off ered as an alternative to or in addition to antidepressant drugs for those who did not respond to antidepressant treatment.
Referral to the clinical specialist was reserved for patients who were assessed as having a high suicide risk at any stage, were unresponsive to the earlier treatments, posed diagnostic dilemmas (eg, an elderly patient who has notable memory problems along with depressive symptoms or a patient who has hallucinations in addition to depressive symptoms), had substantial comorbidity with alcohol dependence, had other associated substantial medical problems (eg, a patient who has uncontrolled diabetes or hypertension in addition to depression), or for whom the primary care physician requested a consultation. Every facility team was supported by a clinical specialist who visited about once a month and was also available for consultation on the telephone to discuss cases.
Patients' discharge was either planned (eg, if they were deemed to have recovered) or unplanned (eg, if they did not return for reviews despite adherence management procedures).
For the control intervention (enhanced usual care), physicians and patients in usual care practices received screening results and were given the treatment manual prepared for primary care physicians. Physicians were allowed to start treatments of their choice.
Process indicators assessing the fi delity and quality of the intervention were obtained from four sources: the separate clinical records maintained by the lay health counsellor and the clinical specialist, antidepressant use from the clinic records, and quality assessments done for every component of the intervention. Quality assessments for intervention components were made by direct observation or through transcripts of sessions, and were rated by senior clinicians. The only possible process indicator in the enhanced usual care group was antidepressant use.
Primary and secondary outcomes
The primary outcome was the proportion of patients who recovered from common mental disorders as defi ned by the International Statistical Classifi cation of Diseases and Related Health Problems-10th revision (ICD-10) at 6 months. The secondary outcome was the severity of depression and anxiety symptoms, assessed at 6 months.
The primary and secondary outcomes were assessed with the CIS-R, which generates two outputs: an ICD-10 diagnosis derived from a computer algorithm and a total score indicating the overall severity of symptoms. 21 
Statistical analyses
Our sample size estimates have been described in detail in our protocol. 22 Briefl y, we assumed a coeffi cient of variation of 0·2; prevalence of common mental disorders (as defi ned by ICD-10) of 66% in participants who screened positive; and a follow-up of 75% at 6 months. The resulting sample size of 100 screen-positive participants in 24 clusters provides more than 90% power to detect a diff erence in recovery rates of 70% in the intervention group versus 50% in the control group (enhanced usual care). The higher rates of ICD-10 cases and follow-up rates recorded during phase 1 led to a downward re-estimation of the sample sizes in phase 2 to 80 screen-positive participants per cluster.
All analyses were done in Stata (version 11.0). Participants were divided into four a-priori diagnostic groups on the basis of their clinical diagnosis at baseline. Screen-positive cases were all participants in the trial-ie, patients who had been assessed with the GHQ-12 and identifi ed to have a probable common mental disorder. For these patients, identifi cation of a common mental disorder could be established through routine screening in primary care; a lengthy diagnostic interview would not be feasible because of the longer duration needed. ICD-10 cases comprised the subgroup of screen-positive patients who had a diagnosable CMD assessed with the CIS-R; these patients were the primary analysis group. Subthreshold cases were the subgroup of screen-positive patients who did not meet ICD-10 diagnostic criteria for CMD on the CIS-R. Depression cases were the subgroup of ICD-10 patients with the specifi c diagnosis of depression, assessed with the CIS-R; these cases included patients with comorbidity with anxiety.
As per the trial protocol, 22 the primary analysis was the diff erence across groups in the proportion of patients with these disorders who recovered at 6 months at baseline according to the ICD-10 criteria (ie, are no longer patients). Secondary analyses were also evaluated at 6 months and comprised the diff erences across groups in: the proportion of depression cases who recovered; the prevalence of patients who met ICD-10 criteria for common mental disorders among screen-positive cases and subthreshold cases; and the mean total CIS-R score in each diagnostic group.
Analyses were based on cluster-level summary measures, because individual-level regression methods are not robust when there are few clusters per group. 26 For binary outcomes, the eff ect was measured by the risk ratio and risk diff erence. The stratum-specifi c RRs were calculated as the ratio of the geometric mean risks between groups for each of the six strata, and the overall risk ratio was estimated as the weighted-average of these stratum-specifi c RRs. An approximate variance for the log (mean risk) in each group was obtained from the residual mean square from a two-way analysis of variance of community log-risk on strata and study group. A 95% CI for the risk ratio was calculated from this variance with a stratifi ed t test with 12 degrees of freedom. 26 Similarly, a 95% CI for the risk diff erence was obtained from an analysis of variance of the mean risk on strata and study group. For continuous outcomes (CIS-R score), the measure of eff ect was the mean diff erence between groups, and these outcomes were analysed in an analogous method on the basis of mean scores in every facility. Secondary planned analyses assessed the eff ect of the intervention separately in the two types of facilities, with assessment of eff ect-modifi cation of the intervention eff ect by facility type estimated using Welch's t test to compare log risk ratios in the two groups. 27 Predefi ned sensitivity analyses included adjustment for age, sex education level, and baseline CIS-R score. Finally, we did a sensitivity analysis to investigate the eff ect of missing data by using multiple imputation with chained equations to create multiple datasets, which were analysed with an individual level Poisson regression model, allowing for within-cluster correlation using generalised estimating equations. Analyses were completed on an intention-to-treat basis (ie, analysis included the 1160 patients randomly assigned to the collaborative stepped-care group who were seen at 6 months and the 1269 patients randomly assigned to the enhanced usual care group who were seen at 6 months). The trial is registered with ClinicalTrials.gov, number NCT00446407. 
Role of the funding source
The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. HAW and VP had full access to all the data; VP had the fi nal responsibility for decision to submit for publication.
Results
The fi gure shows the trial profi le. One GP cluster was replaced by a back-up within a month of randomisation because of small patient numbers. All 24 clusters were followed to the end of the trial 20 352 patients were screened, of whom 3816 (18·8%) screened positive for common mental disorders and 3434 (16·9%) were eligible to participate (fi gure). Of these patients, 1360 were enrolled in the collaborative stepped-care group and 1436 in the enhanced usual care group. Participants who did not consent tended to be younger than those who did consent (webappendix p 1). 1160 participants (85%) in the collaborative stepped-care group and 1269 (88%) in the control group completed the 6-month outcome assessment. Participants who were not followed up at 6 months were more likely to be younger and male;
however, we noted no diff erences in terms of intervention group, facility type, or baseline diagnostic group (webappendix p 2). 1098 patients met ICD-10 criteria for common mental disorders at baseline in the intervention group (81% of patients who screened positive) and 1144 (80%) in the control group. Of these, 944 (86%) in the intervention group and 1017 (89%) in the control group were seen at the 6-month outcome assessment. We recorded little intra-cluster correlation (0·03), and the coeffi cient of variation (k) for prevalence of these disorders at baseline in all patients who screened positive was 0·08. Table 2 shows the sociodemographic and clinical characteristics of the two groups. The trial population was mostly female, and the mean age was 46·3 years (SD 13·3). Of the 2242 patients (81%) who met ICD-10 criteria for these disorders at baseline (1098 in the collaborative stepped-care group; 1144 in the enhanced usual care group), 774 (35%) had depression, including comorbid anxiety disorders (304; 470). The most common diagnosis was mixed anxiety-depressive disorder (n=1032; 46% of patients with common mental disorders); the remaining 436 (19%) had a pure anxiety disorder (233; 203). Generally, See Online for webappendix distribution of these disorders between groups was similar; although participants in the enhanced usual care group were more likely to have depression, the proportion of patients with these disorders according to ICD-10 and mean CIS-R scores were similar (table 2) .
The collaborative stepped-care intervention had a small eff ect on recovery for patients who met ICD-10 criteria for common mental disorders at 6 months (table 3). The eff ect was larger in PHC participants and not evident in GP participants (table 3). The intervention had no signifi cant eff ect on recovery from common mental disorders in patients with depression (table 3). The eff ect on recovery from common mental disorders persisted when missing values were imputed (risk ratio 1·19, 95% CI 1·02-1·40 on imputed analysis vs risk ratio 1·22, 95% CI 1·00-1·47 on complete case analysis). The number needed to treat for the overall primary outcome was eight (95% CI 4-63), which was four in the PHC clinics (95% CI 2-20).
There was modest evidence of an eff ect on the overall prevalence of common mental disorders at 6 months in screen-positive cases, with prevalence halved in PHCs, although there was no eff ect in GP facilities (table 4). In the subthreshold cases, there was evidence of a protective eff ect of the intervention overall, which did not diff er by facility type (table 4) .
For each diagnostic group, the mean CIS-R score was lower in the collaborative stepped-care than in the enhanced usual care group at 6 months (table 5) . Furthermore, in the screen-positive cases, the intervention had a positive eff ect in PHCs for patients who met ICD-10 criteria for common mental disorders, and weak evidence of a positive eff ect for patients with depression, although it had no eff ect in GP facilities (table 5) .
Adjustment for baseline factors made little diff erence to all the fi ndings (data not shown). Mean diff erence (95% CI); p value for diff erence -2·14 (-4·32 to 0·04); 0·05 -4·84 (-8·48 to -1·20); 0·02 0·63 (-2·76 to 4·02); 0·68 0·01
Depression cases
Collaborative stepped care
Mean diff erence (95% CI); p value -1·01 (-3·63 to 1·61); 0·42 -4·30 (-9·58 to 0·98); 0·09 2·38 (-1·29 to 6·05); 0·17 0·02
Screen-positive cases
Mean diff erence (95% CI); p value -2·15 (-4·20 to -0·10); 0·04 -4·75 (-8·86 to -0·64); 0·03 0·52 (-2·36 to 3·40); 0·69 0·02
Subthreshold cases
Mean diff erence (95% CI); p value -1·90 (-4·01 to 0·20); 0·07 -2·87 (-8·09 to 2·34); 0·20 -0·91 (-3·25 to 1·44); 0·40 0·38
PHC=public primary health centre. GP=general practitioner. ICD-10=International Statistical Classifi cation of Diseases and Related Health Problems-10th revision. CIS-R=revised clinical interview schedule. *For eff ect modifi cation by facility type. The original target for coverage was reached for most indicators (table 6), although among patients receiving interpersonal psychotherapy the proportion who completed at least six sessions was lower than expected. A major barrier was the indirect and direct costs associated with the requirement for patients to return to the facility for regular sessions. More than half of all patients had a planned discharge from the programme. The number of quality assessments also exceeded the targets set for the trial (data not shown). In the control group, of those on antidepressant drugs, 45 (10·2%) completed 3 months of treatment in the PHC phase and 34 (11·3%) in GP phase.
There were seven serious adverse events (three deaths and four suicide attempts) in the collaborative steppedcare group and 12 in the enhanced usual care group (six deaths and six suicide attempts). None of the deaths were from suicide.
Discussion
Findings from this study have shown that overall there was modest evidence for a benefi cial eff ect of the intervention on recovery from common mental disorders at 6 months according to the ICD-10 criteria, with a statistically signifi cant eff ect in PHCs but no eff ect in private facilities. We recorded no eff ect of the intervention on the smaller subgroup of patients with depression. Secondary analyses showed that the intervention had a consistent eff ect in PHCs but not in private facilities for all baseline diagnostic groups apart from depression. The intervention also suggested some preventive eff ect in reducing the prevalence of common mental disorders in subthreshold cases.
The results of the MANAS trial indicate that such a collaborative-stepped care intervention delivered by trained lay health counsellors can improve recovery rates for patients with common mental disorders in public primary care settings, but not in private primary care settings. The recorded eff ects might underestimate the true eff ect because two key components of the intervention (provision of screening results to patients and physicians, and evidence-based guidelines to the physician) were off ered in both groups. The recovery rates in the intervention groups in both types of facilities are similar to those reported by other trials (panel) and to our original hypothesis. 22 We recorded similar recovery rates in the private GP control group; thus, private GPs do well irrespective of presence of a lay health counsellor. By contrast, PHCs benefi t from the addition of a lay health counsellor, and the intervention appeared eff ective for the treatment and prevention of common mental disorders.
There are several possible explanations for these results. Although the PHC facilities were indicative of typical centres, having been selected randomly from the eligible sampling frame, the participating GPs were likely to represent a subgroup of physicians who were motivated to improve the quality of care for common mental disorders because of the diffi culties in obtaining a representative sampling frame. Other explanations could include the style of GP interactions with patients, which might have similar characteristics to that of the lay health counsellors (eg, better continuity of care with the same physician). By contrast, in the PHCs, larger numbers of patients tend to be seen for shorter periods by a doctor and the privacy needed to discuss interpersonal diffi culties is not assured. This diff erence has also been reported in the WHO international study 3 of common mental disorders in general health-care settings, which categorised primary care facilities into two distinct types: individual, personalised client-centred care model; and a collective clinic-centred care model. The personalised types of health-care settings showed better performance indicators than did the collective model, suggesting that the organisation of health care might directly aff ect the outcomes. We are investigating these hypotheses through qualitative interviews with GPs to ascertain the extent to which usual care by these GPs approximated the care provided by the lay health counsellors. Finally, characteristics of patients diff ered by clinic type (webappendix p 3). The absence of an overall eff ect in the subgroup of patients with depression might be partly attributable to lower power to detect a clinically signifi cant eff ect in this subgroup, inadequate guidelines to triage depression cases, and inadequate intensity of the treatments, particularly the failure to deliver interpersonal psychotherapy as planned. Future analyses will assess the eff ect of the intervention at short-term and long-term secondary endpoints.
The strengths of this trial include: large samples from rural and urban populations with inclusion of both public and private facilities; high follow-up rates; high levels of fi delity and quality of the intervention (with the exception of low coverage of interpersonal psychotherapy); and consistent documentation of eff ect in PHCs for each diagnostic group apart from depression.
Panel: Research in context
Systematic review Systematic reviews show that antidepressant drugs and brief psychological treatments are eff ective for the treatment of common mental disorders 28 and that collaborative stepped-care models are eff ective for their delivery in primary health care.
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Interpretation
The results of the MANAS trial suggest that a collaborative stepped-care intervention provided by trained lay health counsellors can improve recovery rates for patients with common mental disorders in public primary care settings, which are characterised by a collective clinic-centred model of care. However, the results of this trial indicate that this intervention is not eff ective for private primary care settings, characterised by a personalised client-centred model of care.
Additionally, we were able to confi rm the high specifi city of our screening procedure in a real-world context. About 13% of patients were not seen at the 6-month outcome, and these patients were more likely to be younger and male. However, separate models by agegroup and sex were fi tted, and showed no evidence of diff erential recovery rates by sex or age. Missing data are thus unlikely to aff ect the results.
We recommend that the collaborative stepped-care intervention should be extended to clinics run by public primary health-care facilities. Screening is feasible because of the high prevalence of common mental disorders in primary care attenders, the brevity of screening instruments 29 and increasing literacy rates in many countries that makes self-completion feasible, and, as we noted, a relatively high specifi city of diagnosis of these disorders by ICD-10 criteria. Screening might have been a crucially important component accounting for the good outcomes in the control GP facilities. Lay health counsellors could undertake several health-care roles, are fairly low cost to recruit, and are readily available in most developing countries. However, the fact that the intervention had no eff ect on the smaller subgroup of patients with depression also indicates the need for feasible methods for its detection and for more intensive treatments for these patients-for example, psychological treatments that are more specifi c to the needs of the patient or more aggressive pharma cotherapy. 30 In conclusion, results from the MANAS trial indicate the eff ectiveness of a lay health counsellor-led collaborative stepped-care intervention for common mental disorders in public primary health-care facility attenders in India. This evidence should be used to improve services for common mental disorders in settings for which mental health professionals are scarce.
Contributors VP, HAW, and BK were responsible for the overall design of the trial with inputs from RA, MK, and GS. NC, SP, SC and BB were responsible for the conduct of the trial. SN was responsible for data management. HW, SM, and MdS did the data analysis with inputs from MK. All authors contributed to the trial design, conduct, or analysis, were involved in preparing the report, and approved the fi nal submitted version.
Confl icts of interest
All authors' expenses related to this trial were paid for by the Wellcome Trust grant through partner institutions. We declare that we have no other confl icts of interest.
